| Date | Acquired company | Acquiring company | Amount | Related |
|---|---|---|---|---|
| 2017-06-26 | Innova Biosciences (UK) | Sygnis (Germany) | ||
| 2017-06-26 | Genoma Group (Italy) | Eurofins Scientific (Luxembourg) | undisclosed | |
| 2017-06-13 | Alphora Research (Canada) | Eurofins Scientific (Luxembourg) | undisclosed | Technology - Services |
| 2017-06-09 | Actelion (Switzerland) | Johnson&Johnson (J&J) (USA - NJ) | $ 30 billion | Rare diseases |
| 2017-06-02 | GATC Biotech (Germany) | Eurofins Scientific (Luxembourg) | undisclosed | Technology - Services |
| 2017-05-09 | iLab, Biosphere and two specialty clinical testing laboratories (France) | Eurofins Scientific (Luxembourg) | diagnostic | |
| 2017-05-04 | MVZ für Laboratoriumsmedizin am Hygiene-Institut GmbH (Hygel) (Germany) | Eurofins Scientific (Luxembourg) | diagnostic | |
| 2017-05-03 | MiNA Therapeutics (UK) | Sosei (Japan) | £ 175 million | Cancer - Oncology |
| 2017-04-24 | Merck KGaA's biosimilar business (Germany) | Fresenius Kabi (Germany) | € 670 million plus royalties on future product sales | Biosimilar |
| 2017-04-24 | Akorn (USA - IL) | Fresenius Kabi (Germany) | $4.75 billion | generics |
| 2017-04-11 | Asymptote (UK) | GE Healthcare (USA - WI) | undisclosed | Technology - Services |
| 2017-04-03 | assets and relevant business related to the CELLSEARCH® Circulating Tumor Cell System from Janssen Diagnostics (USA - PA) | Menarini-Silicon Biosystems, a Menarini group company (Italy) | undisclosed | Cancer - Oncology - Diagnostic |
| 2017-03-30 | Symetis (Switzerland) | Boston Scientific (USA - MA) | $435 million | Medical devices Cardiovascular diseases |
| 2017-03-23 | Agalimmune (UK) | Bioline Rx (Israel) | $6 million and additional future payments based on development and commercial milestones | Cancer - Oncology |
| 2017-03-23 | Euchloe Bio (Singapore) | Tessa Therapeutics (Singapore) | undisclosed | Cancer - Oncology |
| 2017-03-20 | Mallinckrodt's intrathecal therapy business (UK) | Piramal (India) | $203 million | |
| 2017-03-17 | Threshold Pharmaceuticals (USA - CA) | Molecular Templates (USA - TX) | Cancer - Oncology | |
| 2017-03-16 | PCT, a Caladrius Company (USA - CA) | Hitachi Chemical Co. America (USA - CA) | $75 million in cash and $5 million revenue-based milestone | Technology - Services Production - Manufacturing |
| 2017-02-28 | Genticel (France) | Genkyotex (Switzerland) | € 30 million | Cancer-Oncology Infectious diseases |
| 2017-02-16 | Ariad Pharmaceuticals (USA - MA) | Takeda Pharmaceutical (Japan) | $5.2 billion | Cancer - Oncology |
